68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?

84Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

Background DOTATATE-based radionuclides have added new options in the diagnosis and treatment of meningiomas; however, a reliable predictor of tumor growth has still not been established. Methods We analyzed 64 meningiomas imaged with 68Ga-DOTATATE PET. Tumor growth rates were calculated by volumetric analysis of sequential MRI scans. Maximums of standardized uptake values (SUVmax) were correlated with tumor growth and covariates. Results World Health Organization (WHO) grades I and II meningiomas showed a correlation of SUVmax and tumor growth rate (meningiomas limited to the intracranial compartment: r = 0.757, P

Cite

CITATION STYLE

APA

Sommerauer, M., Burkhardt, J. K., Frontzek, K., Rushing, E., Buck, A., Krayenbuehl, N., … Kuhn, F. P. (2016). 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? Neuro-Oncology, 18(7), 1021–1027. https://doi.org/10.1093/neuonc/now001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free